Skip to main content
Elsevier
View Cart
openUserAccount

Books in Neuropharmacology

BooksJournals
21-30 of 30 results in All results

Pathophysiology, Pharmacology and Biochemistry of Dyskinesia

  • 1st Edition
  • Volume 98
  • September 7, 2011
  • Jonathan Brotchie + 2 more
  • English
  • eBook
    9 7 8 - 0 - 1 2 - 3 8 1 3 2 9 - 9
Published since 1959, International Review of Neurobiology is a well-known series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. Led by an internationally renowned editorial board, this important serial publishes both eclectic volumes made up of timely reviews and thematic volumes that focus on recent progress in a specific area of neurobiology research. This volume reviews existing theories and current research surrounding the movement disorder Dyskinesia.

Pharmacology of 5-HT6 receptors, Part II

  • 1st Edition
  • Volume 96
  • March 1, 2011
  • Franco Borsini
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 8 5 9 0 2 - 0
  • eBook
    9 7 8 - 0 - 1 2 - 3 8 5 9 0 3 - 7
The serotonin 5-HT6 receptor represents a novel pharmacological target whose impact on physiopathology of CNS functions remains undetermined. Some receptor antagonists have been synthesized, and they show a modulatory role in learning and memory processes and food intake. The pharmacology of 5-HT6 receptor agonists is still under evaluation. However, both 5-HT6 antagonists and agonists seem to exert potential antidepressant activity. Recently, a second messenger system has been discovered. 5-HT6 receptor function is becoming more and more intriguing. Thus, the aim of the present book is to try to clarify the pharmacology of 5-HT6 receptors.

Pharmacology of 5-HT6 receptors, Part I

  • 1st Edition
  • Volume 94
  • November 29, 2010
  • Franco Borsini
  • English
  • eBook
    9 7 8 - 0 - 1 2 - 3 8 4 9 7 7 - 9
The serotonin 5-HT6 receptor represents a novel pharmacological target whose impact on physiopathology of CNS functions remains undetermined. Some receptor antagonists have been synthesized and they show a modulatory role in learning and memory processes and food intake. The pharmacology of 5-HT6 receptor agonists is still under evaluation. However, both 5-HT6 antagonists and agonists seem to exert potential antidepressant activity. Recently, a second messenger system has been discovered. 5-HT6 receptor function is becoming more and more intriguing. Thus, the aim of the present book is to try to clarify the pharmacology of 5-HT6 receptors.

Nanoneuroscience and Nanoneuropharmacology

  • 1st Edition
  • Volume 180
  • December 3, 2009
  • Hari S. Sharma
  • English
  • Hardback
    9 7 8 - 0 - 4 4 4 - 5 3 4 3 1 - 6
  • eBook
    9 7 8 - 0 - 0 8 - 0 9 6 2 2 4 - 5
This volume presents articles from the leading experts in the field in nanobiotechnology, providing students and researchers with a comprehensive review of the newly emerging area of neuroscience. All aspects of nanomaterials induced alteration in brain function are considered. Basic chapters on methods and ways to enhance nano-drug delivery into the brain are presented as well as chapters on functional and structural changes in the CNS, including gene expression and related issues. Particular attention is given to possible therapeutic advancement regarding nano-drug formulation and their role in neuroprotection.

Advances in Neuropharmacology

  • 1st Edition
  • Volume 85
  • July 30, 2009
  • Giacinto Bagetta + 3 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 7 4 8 9 3 - 5
  • eBook
    9 7 8 - 0 - 0 8 - 0 9 5 3 8 6 - 1
This volume provides a broad overview of important new advances in the field of Neuropharmacology. In 20 chapters, a selection of international contributors discuss topics including endocannabinoid function, pain, stress, astrocytes etc, and new possibilities for treatments of neurological diseases with neuropharmacological approaches.

Pharmacology

  • 1st Edition
  • June 19, 2009
  • Miles Hacker + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 6 9 5 2 1 - 5
  • eBook
    9 7 8 - 0 - 0 8 - 0 9 1 9 2 2 - 5
Pharmacology meets the rapidly emerging needs of programs training pharmacologic scientists seeking careers in basic research and drug discovery rather than such applied fields as pharmacy and medicine. While the market is crowded with many clinical and therapeutic pharmacology textbooks, the field of pharmacology is booming with the prospects of discovering new drugs, and virtually no extant textbook meets this need at the student level. The market is so bereft of such approaches that many pharmaceutical companies will adopt Hacker et al. to help train new drug researchers. The boom in pharmacology is driven by the recent decryption of the human genome and enormous progress in controlling genes and synthesizing proteins, making new and even custom drug design possible. This book makes use of these discoveries in presenting its topics, moving logically from drug receptors to the target molecules drug researchers seek, covering such modern topics along the way as side effects, drug resistance, pharmacogenomics, and even nutriceuticals, one in a string of culminating chapters on the drug discovery process. The book is aimed at advanced undergraduates and beginning graduate students in medical, pharmacy, and graduate schools looking for a solid introduction to the basic science of pharmacology and envisioning careers in drug research.

The Pharmacology of Neurogenesis and Neuroenhancement

  • 1st Edition
  • Volume 77
  • January 2, 2007
  • Donard Dwyer
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 7 3 6 7 8 - 9
  • eBook
    9 7 8 - 0 - 0 8 - 0 4 6 9 1 8 - 8
Currently, few drugs are available for the effective treatment of neurodegenerative diseases and neurodevelopmental disorders. Recent advances in neuroscience research offer hope that future strategies for treating these brain disorders will include neurogenesis and neuroenhancement as therapeutic endpoints. This volume reviews cutting-edge findings related to the pharmacological aspects of neurogenesis and neuroprotection. A broad range of topics are covered from basic lab bench research to drug discovery efforts and important clinical issues. This collection of reviews is a perfect way to become acquainted with these exciting new fields in the space of a single volume. Chapters are written with a general audience in mind, but with enough high-level discussion to appeal to specialists and experts as well. The authors have done an excellent job of challenging current paradigms and pushing the boundaries of exploration in keeping with the pioneering spirit that gave rise to these emerging areas of research. Consequently, this will be an indispensable resource for many years to come.

Neuropeptide Y and Drug Development

  • 1st Edition
  • November 15, 1996
  • Lars Grundemar + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 0 4 9 9 0 - 2
  • eBook
    9 7 8 - 0 - 0 8 - 0 5 3 7 4 5 - 0
Neuropeptide Y (NPY) is a ubiquitous and important messenger in the nervous system, with a wide range of physiological roles. It is involved in the body energy balance and is one of the most potent stimuli of food intake known. NPY also acts to regulate central and peripheral autonomic functions. This book, written by academic and industrial experts in the field, links the most recent basic experimental knowledge about NPY and its receptors with areas of clinical importance. This book will be of interest to those working in all areas of research affected by NPY, such as food intake and energy homeostasis, cardiovascular regulation and G-protein-coupled receptors, as well as those interested in the development of drugs as NPY targets.

Neurotransmitter Receptors

  • 1st Edition
  • Volume 24
  • March 17, 1994
  • F. Hucho
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 8 6 0 8 4 - 8
This comprehensive compilation provides a wealth of information on receptor sequences produced by recombinant DNA techniques used in combination with classical biochemistry. To minimize redundancies in this wealth of information, only a few receptors (some of which are typical for a whole group of similar receptors, others which are presently of special interest) are dealt with in a full-size chapter. Others are represented in the TIPS Receptor Nomenclature Supplement which is included as a special feature in this book, making this volume more useful as a receptor handbook.

Introduction to Neuropharmacology

  • 1st Edition
  • January 30, 1989
  • Philip B. Bradley
  • English
  • eBook
    9 7 8 - 1 - 4 8 3 1 - 8 3 6 8 - 8
Introduction to Neuropharmacology presents the action of drugs as it relates to nervous system. It discusses the purposes into which drugs are use (e.g. as contraceptives and anti-riot agents). It addresses the differences between physiology and pharmacology. Some of the topics covered in the book are the factors affecting responses to drugs; properties of drugs; the kinetics of drug-receptor interactions; dose-response relationship; the principles of synaptic transmission; criteria for synaptic transmitters; somatic motor system; drugs affecting neuromuscular transmission; and drugs which act post-synaptically. The venoms and toxins that affect neuromuscular transmission are covered. The subdivisions of the autonomic nervous system are discussed. The text describes the autonomic ganglion stimulants. A study of the drugs mimicking parasympathetic stimulation is presented. A chapter is devoted to the drugs with antagonist actions on adrenoceptors. Another section focuses on the clinical uses of local anaesthetic drugs and the neurotransmitters in the central nervous system. The book can provide useful information to dentists, doctors, pharmacists, neurologists, students, and researchers.